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Correlation between Radiologic and Pathologic Tumor Size in 
Localized Renal Cell Carcinoma
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Purpose: To evaluate the accuracy of radiologic tumor size for making decisions regard-
ing nephron-sparing surgery of localized renal cell carcinomas (RCCs), we compared 
tumor size measured by a preoperative radiologic modality with that measured in the 
pathologic specimen.
Materials and Methods: Between January 2003 and December 2007, a total of 186 pa-
tients with pT1 or pT2 RCC underwent radical or partial nephrectomy at our institute. 
We excluded 11 patients who had preoperative arterial embolization (n=9) or positive 
surgical margins (n=2), and a total of 175 patients were included in this study. 
Radiologic size was defined as the largest diameter on computed tomography (CT), and 
pathologic size was defined as the largest diameter of the surgical specimen of the 
tumor. We retrospectively analyzed the difference between radiologic and pathologic 
tumor size.
Results:  The radiologic and pathologic tumor sizes did not significantly differ 
(4.98±2.82 cm vs. 4.55±2.70 cm, respectively, p=0.152). In the subgroup analysis, the 
size difference was statistically significant only for tumor sizes of less than 6 cm. The 
size difference was largest in tumors of 3 to 4 cm, for which mean the radiologic size 
was 0.63±1.19 cm larger than the mean pathologic size (p=0.002). Histologic type had 
no significant influence on the difference between radiologic and pathologic size.
Conclusions: The tumor size of RCCs in preoperative CT seems to correlate well with 
pathologic tumor size. However, CT imaging may overestimate the size of a tumor in 
the small mass group (less than 6 cm). These results should be considered when making 
decisions about nephron-sparing surgery.
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INTRODUCTION
Tumor size is known as an important prognostic factor in 
localized renal cell carcinoma (RCC), and staging and se-
lection of an appropriate treatment depend on the size of 
the tumor [1]. Most research on the prognostic value of tu-
mor size has been based on pathologic size rather than ra-
diologic size [2,3]. On the other hand, treatment including 
nephron-sparing surgery (NSS) is decided upon according 
to radiologic size. Novick reported that, with the accumu-
lation of longer-term data, a size criterion has gained grad-
ual acceptance for elective NSS [4]. He also reported that 
radical nephrectomy and NSS are equally effective cura-
tive treatments for patients who present with a single, 
small (＜4 cm), and clearly localized RCC (4-6 cm). In his 
opinion, although the long-term functional advantage of 
NSS when there is a normal opposite kidney remains to be 
shown definitively, the benefits of maximal nephron pres-
ervation may include a decreased risk of progression to 
chronic renal insufficiency and end-stage renal disease. 
Therefore, it is important to define the correlation and 
agreement between radiologic size and pathologic size, es-
pecially for patients who are candidates for NSS of a lo-
calized RCC. We studied the relationship between radio-
logic tumor size, as determined by preoperative computed 
tomography (CT), and pathologic tumor size from a renal 
surface series.Korean J Urol 2010;51:161-164
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TABLE 1. Characteristics of the 175 patients with localized renal 
cell carcinomas
Characteristics No. of patients (%)
No. of patients
No. of male/female
Mean age, years (range)
Average tumor size (cm, Mean±SD)
　Radiologic
　Pathologic
Pathologic stage
　pT1a
　pT1b
　pT2
Histologic type
　Clear
　Chromophobe
　Papillary
　Sarcomatoid
Nephrectomy type
　Radical
　Partial 
Fuhrman grade
　I
　II
　III
　IV
175
116/59
54.0 (14-79)
4.98±2.82
4.55±2.70
100 (57)
50 (29)
25 (14)
147 (84)
13 (7)
11 (6)
4 (3)
154 (88)
21 (12)
3 (2)
119 (68)
46 (26)
7 (4)
TABLE 2. Differences in radiologic and pathologic tumor size according to radiologic size range
Radiologic size
range (cm)
No. of
patients
Pathologic tumor size
(cm, Mean±SD)
Radiologic tumor size
(cm, Mean±SD)
Difference
(cm, Mean±SD)
p-value
≤1
1.1-2.0
2.1-3.0
3.1-4.0
4.1-5.0
5.1-6.0
6.1-7.0
＞7
6
9
33
36
29
20
13
29
0.78±0.12
1.53±0.24
2.33±0.25
3.27±0.23
4.20±0.24
5.14±0.24
6.15±0.24
9.46±2.44
0.93±0.08
1.93±0.30
2.61±0.26
3.90±0.28
4.70±0.26
5.59±0.24
6.67±0.26
9.67±2.78
0.15±0.08
0.40±0.52
0.28±0.42
0.63±1.19
0.50±0.47
0.46±0.83
0.52±0.91
0.21±1.24
　0.039
a
　0.028
a
　0.003
a
　0.002
a
＜0.001
a
　0.037
a
　0.057
　0.770
Total 175 4.55±2.70 4.98±2.82 0.43±0.88 　0.152
SD: standard deviation, 
a: statistically significant
MATERIALS AND METHODS
The medical records of 186 patients treated by radical 
nephrectomy or partial nephrectomy for localized RCC 
from January 2003 to December 2007 were retrospectively 
reviewed. We excluded 11 patients who had preoperative 
arterial embolization (n=9) or positive surgical margins 
(n=2), and a total of 175 patients were included in this 
study.
　All patients underwent an intravenous contrast- en-
hanced abdominal CT scan before surgery, and the results 
of that were interpreted by a single experienced abdominal 
imaging radiologist.
　The CT was the 16-channel multidetector type and the 
slice thickness was 0.5 mm. The size of the tumor on CT was 
measured in four axes: superior to inferior, anterior to pos-
terior, oblique, and left to right. The largest of these four 
measurements was defined as the radiologic tumor size. 
The pathologic tumor size was defined as the largest diame-
ter of the tumor examined just after extraction of the speci-
men without formalin fixation. In patients with multiple 
unilateral tumors of the same histologic subtype, the larg-
est tumor was included. The tumors were divided into size 
ranges by radiologic size. The mean values of radiologic 
sizes, pathologic sizes, and the difference were calculated. 
Student’s t-test was used to compare the mean values. A 
5% level of significance was used for all statistical testing, 
and all statistical tests were two-sided.
RESULTS
The mean patient age was 54.0 years (range, 14-79 years); 
of 175 patients, 116 were men and 59 were women. The 
characteristics of the 175 patients with localized RCCs are 
shown in Table 1.
　The mean radiologic and pathologic tumor sizes for all 
175 patients did not differ significantly (4.98±2.82 cm vs. 
4.55±2.70 cm, respectively, p=0.152). Table 2 lists the 
mean radiologic and pathologic sizes of the tumors, which 
were divided into 1 cm ranges by radiologic size. The mean 
radiologic tumor size was larger than the pathologic tumor 
size for all sizes. In particular, in tumors less than 6 cm, 
the difference between radiologic and pathologic tumor 
size was statistically significant (p＜0.05). The largest dif-
ference was for tumors 3 to 4 cm in size, for which the mean 
radiologic size was 0.63±1.19 cm larger than the mean 
pathologic size (p=0.002). No significant difference was 
seen between the radiologic and pathologic tumor size for 
tumors larger than 6 cm (Table 2).
　Table 3 shows the mean radiologic and pathologic sizes 
of tumors divided into pT1a, pT1b, and pT2 groups. In pT1a 
and pT1b tumors, the difference between mean radiologic 
and pathologic tumor size was statistically significant 
(0.45±0.82 cm and 0.50±0.73 cm, respectively; p=0.002, 
p=0.011). However, in pT2 tumors, no significant differ-Korean J Urol 2010;51:161-164
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TABLE 3. Differences in radiologic and pathologic tumor size according to pathologic stage
Pathologic stage
No. of
patients
Pathologic tumor size
(cm, Mean±SD)
Radiologic tumor size
(cm, Mean±SD)
Difference
(cm, Mean±SD)
p-value
pT1a
pT1b
pT2
100
50
25
2.82±0.82
5.37±0.81
9.85±2.41
3.27±1.20
5.87±1.07
10.04±3.05
0.45±0.82
0.50±0.73
0.19±1.32
0.002
a
0.011
a
0.810
Total 175 4.55±2.70 4.98±2.82 0.43±0.88 0.152
SD: standard deviation, 
a: statistically significant
TABLE 4. Differences in radiologic and pathologic tumor size according to histologic type
Histologic type
No. of
patients
Pathologic tumor size
(cm, Mean±SD)
Radiologic tumor size
(cm, Mean±SD)
Difference
(cm, Mean±SD)
p-value
Clear cell
Non clear cell
147
28
4.44±2.38
5.15±4.05
4.93±2.49
5.22±4.29
0.49±0.84
0.07±1.02
0.850
0.946
Total 175 4.55±2.70 4.98±2.82 0.43±0.88 0.152
SD: standard deviation
ence was seen between radiologic and pathologic tumor 
size (p=0.810) (Table 3). Table 4 lists the mean radiologic 
and pathologic sizes of tumors divided by histologic type in-
to the clear cell type and non clear cell type. In both groups, 
the mean radiologic tumor size was larger than the patho-
logic tumor size (0.49±0.84 cm vs. 0.07±1.02 cm), but there 
was no significant difference between the two groups 
(p=0.850, p=0.946) (Table 4).
DISCUSSION
The increased usage of advanced imaging techniques such 
as ultrasonography or CT has led to an increase in in-
cidental tumors, and the size of incidental tumors tends to 
be smaller [5,6]. Lightfoot et al reported that incidental 
RCC was only 17.5% in the period of 1970 to 1981, but 82.8% 
in the period of 1982 to 1993, when ultrasonography and 
CT were introduced in clinical practice [7]. Recently, it was 
reported that the rate of incidental tumors has increased 
about 40.1% to 46.4%, even in Korea [8-10]. With this in-
crease in incidental localized RCC and decrease in tumor 
size, the treatment modality of RCC has changed. The fre-
quency of NSS, such as partial nephrectomy or cryoa-
blation, and radio frequency ablation, has increased as op-
posed to radical nephrectomy.
　Previously, NSS had only been performed if radical 
nephrectomy was not indicated absolutely or relatively, 
such as with a bilateral RCC, solitary kidney, severe medi-
cal disease, or renal stone, and successful outcomes were 
reported in some cases [11,12]. Hafez et al recommended 
that tumor size be used as an indication for NSS. They re-
ported that patients with renal tumors less than 4 cm have 
better outcomes than do those with tumors greater than 4 
cm when NSS is performed [13]. However, Leibovich et al 
reported that there were no significant differences in re-
currence or distant metastases between patients treated 
with NSS for RCCs less than 4 cm or RCCs of 4 to 7 cm that 
were exophytic or did not reach the collecting system [14]. 
Manikandan et al reported that NSS seems to be as effec-
tive as radical nephrectomy in patients with RCCs up to 4 
cm [15]. Nam et al reported that there were no significant 
differences in complications, recurrence, or metastasis be-
tween patients treated with NSS for RCCs less than 4 cm 
or RCCs of 4 to 7 cm [16].
　The radiologic size of renal tumors is an important factor 
in the decision for NSS; thus, several studies have exam-
ined the relationship between radiologic and pathologic tu-
mor sizes, with varying results. Herr prospectively inves-
tigated 50 patients treated with partial nephrectomy and 
found that the radiologic tumor size was 0.63 cm larger 
than the pathologic size and attributed this difference to 
decreased tumor vascularity after renal artery clamping 
[17]. Schlomer et al reported that a significant difference 
was noted in tumors less than 5 cm, although the mean ra-
diologic and pathologic tumor size for all 133 RCC patients 
was not significantly different [18]. They also found that 
the largest difference was for tumors in the range of 4 to 
5 cm, which may affect decisions to perform NSS in certain 
patients. In our study, the mean radiologic tumor size was 
larger than the pathologic size for all 175 patients, but not 
significantly so. In tumors in the range of less than 6 cm, 
mean radiologic tumor size was significantly larger than 
mean pathologic size, and the difference was largest in tu-
mors of 3 to 4 cm.
　Kanofsky et al retrospectively reviewed 236 patients 
with RCC treated with radical or partial nephrectomy and 
found that radiologic tumor size was commonly over-
estimated; this was more frequently observed for clear cell 
type tumors than for other tumor types, such as papillary 
or chromophobe type [19]. Yaycioglu et al also reported sim-
ilar results [20]. In our study, we found that mean radio-
logic tumor size was larger than mean pathologic tumor Korean J Urol 2010;51:161-164
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size for both clear cell and non?clear cell type tumors, but 
there was no significant difference between the two groups. 
 This study had the disadvantage of a relatively small num-
ber of patients, because the research was conducted at a 
single center. However, as discussed in the Introduction, 
investigating the relationship between radiologic and 
pathologic tumor size has implications for determining 
with assurance when to perform NSS, especially for pa-
tients who are candidates for NSS of a localized RCC.
　Mindful of the results of our study, we are confirming the 
plan for surgical management whether patients with T1 
stage RCC in our cancer center undergo radical neph-
rectomy or NSS. Additional study should be taken into con-
sideration when interpreting the relationship between ra-
diologic and pathologic tumor size. We are making progress 
in a standardized prospective study analyzing radiologic 
and pathologic tumor characteristics along with prognosis, 
which will help to more definitively characterize the rela-
tionship between clinical and pathologic tumor size.
CONCLUSIONS
Preoperative CT imaging may overestimate tumor size in 
RCCs of less than 6 cm. This result may enable us to per-
form NSS with assurance in certain patients with localized 
RCC. A prospective study that includes a comparison of 
prognosis is needed to definitively characterize the proper 
use of clinical tumor size when making decisions regarding 
NSS.
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